Smith & Nephew SNATS, Inc. $SNN Shares Bought by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky grew its position in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 51.0% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 905,100 shares of the medical equipment provider’s stock after purchasing an additional 305,600 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Smith & Nephew SNATS were worth $28,764,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Equity Investment Corp raised its position in shares of Smith & Nephew SNATS by 3.9% during the 4th quarter. Equity Investment Corp now owns 7,502 shares of the medical equipment provider’s stock valued at $246,000 after buying an additional 285 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Smith & Nephew SNATS by 13.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,820 shares of the medical equipment provider’s stock valued at $93,000 after acquiring an additional 334 shares during the last quarter. Cary Street Partners Financial LLC grew its position in Smith & Nephew SNATS by 1.8% in the fourth quarter. Cary Street Partners Financial LLC now owns 20,255 shares of the medical equipment provider’s stock worth $665,000 after acquiring an additional 365 shares during the period. Vise Technologies Inc. grew its position in Smith & Nephew SNATS by 4.7% in the third quarter. Vise Technologies Inc. now owns 9,642 shares of the medical equipment provider’s stock worth $350,000 after acquiring an additional 437 shares during the period. Finally, Quadrant Capital Group LLC increased its stake in Smith & Nephew SNATS by 3.6% during the third quarter. Quadrant Capital Group LLC now owns 12,757 shares of the medical equipment provider’s stock worth $463,000 after acquiring an additional 440 shares during the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew SNATS Stock Down 0.0%

Shares of SNN opened at $30.69 on Monday. Smith & Nephew SNATS, Inc. has a fifty-two week low of $28.56 and a fifty-two week high of $38.79. The firm’s 50 day moving average price is $30.20 and its 200 day moving average price is $32.43. The company has a quick ratio of 1.25, a current ratio of 2.57 and a debt-to-equity ratio of 0.60.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Kepler Capital Markets downgraded Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research report on Thursday, June 4th. Weiss Ratings cut Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, June 11th. The Goldman Sachs Group reissued a “buy” rating on shares of Smith & Nephew SNATS in a research report on Monday, May 25th. Sanford C. Bernstein set a $31.85 price objective on shares of Smith & Nephew SNATS in a report on Monday, May 11th. Finally, Wall Street Zen raised shares of Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Smith & Nephew SNATS currently has a consensus rating of “Hold” and an average target price of $30.93.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.